Clinical, histological and molecular characteristics of lung cancer in patients under 30 years-old

Conclusions: Actionable oncogenic drivers are frequent in 30 year-old and younger patients with NSCLC, notably ALK rearrangements. Such biomarkers should be actively searched, as they open the way for a targeted therapy with better survival and quality of life.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Ducroq, A., Salaün, M., Piton, N., Lamy, A., Guisier, F., Thiberville, L. Tags: Lung Cancer Source Type: research